LifeStance Health Group, Inc. (NASDAQ:LFST) is a top-performing stock, rising by 29.94% on Thursday to close at $6.25 per share due to impressive earnings in Q3. Net income swung to $1.077 million from a $5.9 million loss last year, with total revenues up 16% to $363.8 million year-on-year, supporting a nine-month recovery. CEO Dave Bourdon is optimistic, raising revenue growth outlook to $1.41-$1.43 billion for 2025 and adjusted EBITDA to $146-$152 million. Q4 revenues targeted at $368-$388 million, adjusted EBITDA at $37-$43 million.

Read more at Yahoo Finance: LifeStance (LFST) Soars 30% on Q3 Earnings Blowout